Dave Weiner

Stock Analyst at Piper Sandler

(0.26)

# 4,494

Out of 5,241 analysts

9

Total ratings

25%

Success rate

-11.66%

Average return

Main Sectors:

Healthcare Consumer Discretionary

Top Industries:

Diagnostics & Research Apparel Retail

Stocks Rated by Dave Weiner

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MYGN Myriad Genetics	Maintains: Overweight	$9 → $8.5	$3.65	+132.88%	4	Nov 11, 2025
	LULU lululemon athletica inc.	Upgrades: Buy	n/a	$120.26	-	5	Dec 14, 2017

Myriad Genetics

Nov 11, 2025

Maintains: Overweight

Price Target: $9 → $8.5

Current: $3.65

Upside: +132.88%

lululemon athletica inc.

Dec 14, 2017

Upgrades: Buy

Price Target: n/a

Current: $120.26

Upside: -